Current literature references Asymmetrically Prominent Cortical Veins as a valid marker, but identification is user dependent. We aim to quantify APCV using PWI, greatly reducing the reliance on observer input. This method is a stepping stone for automatic APCV segmentation and has the potential to play a role in establishing a reliable identifier for ischemic penumbra from SWI data.
Data Acquisition: We acquired 167 acute stroke datasets from our collaborators at Shanghai Forth People's hospital. All cases included SWI, PWI, and diffusion weighted images and were collected on a Siemens 3T scanner. For our study, exclusion criteria included brainstem or posterior infarct, hemorrhage affecting SWI, and unavailable PWI data.
Image Analysis: A processor with 4 years of experience and a Stroke Neurologist reviewed the SWI data to determine whether APCV was present. This was used as a gold standard to create two groups: APCV and normal. SWI and PWI sequences were spacially coregistered and Quantitative Susceptibility Maps (QSM) were generated using SPIN software (SpinTech, Inc., Bingham Farms, MI). Maximum intensity projections of QSM were generated to match the slice thickness in PWI (6.5mm including 1.5mm acquisition gap). Relative mean transit time was used to outline a region of interest around the hyperintensity. This ROI was overlayed on the QSM image. After excluding extra parenchymal space and edge artifacts, a symmetrical contralateral region was drawn. A threshold of 90 ppb was applied to both regions. Thresholded areas on every slice were converted into individual objects. Six consecutive pixels were required for a vein to be counted. The number of veins and occupying pixels were summed in both hemisphere for each case and compared.
1. Fisher M. The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis. 2004;17 Suppl 1:1-6.
2. Davis S, Donnan GA. Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014. Cerebrovasc Dis. 2014;38(1):59-72.
3. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903.
4. Ciccone A, Valvassori L, Investigators SE. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(25):2433-2434.
5. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914-923.
6. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34(11):2729-2735.
7. Luo S, Yang L, Wang L. Comparison of susceptibility-weighted and perfusion-weighted magnetic resonance imaging in the detection of penumbra in acute ischemic stroke. J Neuroradiol. 2015;42(5):255-260.
8. Park MG, Yang TI, Oh SJ, Baik SK, Kang YH, Park KP. Multiple hypointense vessels on susceptibility-weighted imaging in acute ischemic stroke: surrogate marker of oxygen extraction fraction in penumbra? Cerebrovasc Dis. 2014;38(4):254-261.
Figure 3: A schematic visualizing the spacial and temporal stages of occlusion within the parenchyma and the cardiovascular result that leads to prominent veins in the affected tissue.
a: subjects with poor collateral flow
b: subjects with good collateral flow
Table showing the resultant number of veins and pixels after segmentation was completed.
* indicates result with one outlier removed